Original Research

Published on 20 May 2021

lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma

in Pharmacology of Anti-Cancer Drugs

Xuewei Zhu
Li Liu
Yang Wang
Jianan Cong
Zhang Lin
Yongsen Wang
Qi Liu
Leiming Wang
Ben Yang
Tao Li

Frontiers in Oncology

doi 10.3389/fonc.2021.651693

3,197 views
20 citations

Brief Research Report

Published on 20 May 2021

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer

in Pharmacology of Anti-Cancer Drugs

Kun Liu
Yan-Chi Li
Yu Chen
Xiao-Bao Shi
Zi-Hao Xing
Zheng-Jie He
Sheng-Te Wang
Wei-Jing Liu
Peng-Wei Zhang
Ze-Zhong Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.680663

3,450 views
8 citations

Review

Published on 20 May 2021

Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma

in Pharmacology of Anti-Cancer Drugs

Shenglong Li

Frontiers in Oncology

doi 10.3389/fonc.2021.664853

16,668 views
59 citations

Original Research

Published on 17 May 2021

Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha

in Pharmacology of Anti-Cancer Drugs

Yuqing Wang
Jie Huang
Qiong Wu
Jingjing Zhang
Zhiyuan Ma
Lucheng Zhu
Bin Xia
Shenglin Ma
Shirong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.668798

3,526 views
7 citations

Original Research

Published on 14 May 2021

The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers

in Pharmacology of Anti-Cancer Drugs

Runzhi Zhu
Yanjie Tu
Jingxia Chang
Haixia Xu
Jean C. Li
Wang Liu
Ahn-Dao Do
Yuxia Zhang
Jinhu Wang
Benyi Li

Frontiers in Oncology

doi 10.3389/fonc.2021.691199

4,636 views
6 citations

Case Report

Published on 13 May 2021

Case Report: High-Level MET Amplification as a Resistance Mechanism of ROS1-Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Jiangping Yang
Ping Zhou
Min Yu
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.645224

3,248 views
9 citations

Review

Published on 13 May 2021

Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights

in Pharmacology of Anti-Cancer Drugs

Jiajia Du
Aoxue Zhang
Jing Li
Xin Liu
Shuai Wu
Bin Wang
Yanhong Wang
Hongyan Jia

Frontiers in Oncology

doi 10.3389/fonc.2021.673340

15,722 views
60 citations

Systematic Review

Published on 12 May 2021

Analysis of Clinical Trials on Therapies for Prostate Cancer in Mainland China and Globally from 2010 to 2020

in Pharmacology of Anti-Cancer Drugs

Kun Chen
Kehua Jiang
Lannan Tang
Xiaolong Chen
Jianxin Hu
Fa Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.647110

3,748 views
4 citations

Original Research

Published on 12 May 2021

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Run-Bin Liang
Yang Zhao
Min-Ke He
Dong-Sheng Wen
Xiao-Yun Bu
Ye-Xing Huang
Zhi-Cheng Lai
Yu-Jie Xu
Anna Kan
Wei Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.619461

4,832 views
16 citations

Original Research

Published on 11 May 2021

Using Population-Based Cancer Registration Data and Period Analysis to Accurately Assess and Predict 5-Year Relative Survival for Lung Cancer Patients in Eastern China

in Pharmacology of Anti-Cancer Drugs

Runhua Li
Min Zhang
Yongran Cheng
Xiyi Jiang
Huijuan Tang
Liangyou Wang
Tianhui Chen
Bicheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.661012

3,038 views
7 citations

Case Report

Published on 10 May 2021

Case Report: Long-Term Survival of a Pediatric Patient With an Intra-Abdominal Undifferentiated Carcinoma of Unknown Primary

in Pharmacology of Anti-Cancer Drugs

Anja Stirnweiss
Hetal Dholaria
Joyce Oommen
Kathy Hardy
Gareth Jevon
Alex H. Beesley
Rishi S. Kotecha

Frontiers in Oncology

doi 10.3389/fonc.2021.590913

2,713 views

Case Report

Published on 04 May 2021

Case Report: Various Abnormalities in Lipid and Glucose Metabolism Induced by Capecitabine

in Pharmacology of Anti-Cancer Drugs

Takatoshi Anno
Tomoki Yamatsuji
Koichi Tomoda
Shuhei Nakanishi
Hideaki Kaneto

Frontiers in Oncology

doi 10.3389/fonc.2021.664475

2,728 views
3 citations

Original Research

Published on 30 Apr 2021

Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p

in Pharmacology of Anti-Cancer Drugs

Danhui Ma
Sinuo Chen
Heming Wang
Jiayi Wei
Hao Wu
Hong Gao
Xinlai Cheng
Taotao Liu
Shi-Hua Luo
Yicheng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.653061

5,058 views
24 citations

Case Report

Published on 29 Apr 2021

The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report

in Pharmacology of Anti-Cancer Drugs

Xiaozhun Huang
Chunling Wang
Teng Ma
Zhangkan Huang
Houhong Zhou
Lin Xu
Renjie Zhang
Jianjun Zhao
Yefan Zhang
Zhen Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.585983

3,101 views
5 citations

Review

Published on 29 Apr 2021

Repositioning of Antiparasitic Drugs for Tumor Treatment

in Pharmacology of Anti-Cancer Drugs

Yan-Qi Li
Zhi Zheng
Quan-Xing Liu
Xiao Lu
Dong Zhou
Jiao Zhang
Hong Zheng
Ji-Gang Dai

Frontiers in Oncology

doi 10.3389/fonc.2021.670804

60,385 views
24 citations

Original Research

Published on 22 Apr 2021

Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer

in Pharmacology of Anti-Cancer Drugs

Wenting Ni
Hui Fan
Xiuqin Zheng
Fangming Xu
Yuanyuan Wu
Xiaoman Li
Aiyun Wang
Shile Huang
Wenxing Chen
Shijun Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.624811

3,049 views
9 citations

Navigation group

Articles

lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer

Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma

Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha

The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers

Case Report: High-Level MET Amplification as a Resistance Mechanism of ROS1-Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer

Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights

Analysis of Clinical Trials on Therapies for Prostate Cancer in Mainland China and Globally from 2010 to 2020

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

Using Population-Based Cancer Registration Data and Period Analysis to Accurately Assess and Predict 5-Year Relative Survival for Lung Cancer Patients in Eastern China

Case Report: Long-Term Survival of a Pediatric Patient With an Intra-Abdominal Undifferentiated Carcinoma of Unknown Primary

Case Report: Various Abnormalities in Lipid and Glucose Metabolism Induced by Capecitabine

Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p

The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report

Repositioning of Antiparasitic Drugs for Tumor Treatment

Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer